Germline Mutations in PALB2, BRCA1, and RAD51C, wich Regulate DNA Recombination Repair, in Patients with Gastric Cancer

ABSTRACT: Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) n...

Full description

Autores:
González Castrillón, Luz María
Cock Rada, Alicia María
Bohorquez Lozano, Mabel Elena
Toa, Ted
Estrada Flórez, Ana Patricia
Suárez Olaya, John Jairo
Brea Fernández, Alejandro
Cameselle Teijeiro, José
Pinto, Carla
Ramos, Irma
Mantilla Morales, Alejandra
Prieto Sánchez, Rodrigo
Corvalán, Alejandro
Norero, Enrique
Álvarez, Carolina
Tapia, Teresa
Carvallo, Pilar
Sahasrabudhe, Ruta
Lott, Paul
Solano, Angela
Neffa, Florencia
Della Valle, Adriana
Yau, Chris
Soares, Gabriela
Borowsky, Alexander
Hu, Nan
He, Li-Ji
Han, Xiao-You
Taylor, Philip R.
Goldstein, Alisa M.
Torres, Javier
Echeverry De Polanco, María Magdalena
Ruiz Ponte, Clara
Rodrigues Teixeira, Manuel António
Carvajal Carmona, Luis Guillermo
Tipo de recurso:
Article of investigation
Fecha de publicación:
2017
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/34012
Acceso en línea:
https://hdl.handle.net/10495/34012
Palabra clave:
Stomach
Estómago
Stomach Neoplasms
Neoplasias Gástricas
Whole Exome Sequencing
Secuenciación del Exoma Completo
Fanconi Anemia Complementation Group N Protein
Proteína del Grupo de Complementación N de la Anemia de Fanconi
BRCA1 Protein
Proteína BRCA1
Recombinational DNA Repair
Reparación del ADN por Recombinación
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2 , BRCA1 , or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.